Skip to main content
Top
Published in: Critical Care 1/2016

Open Access 01-12-2016 | Letter

An evaluation of the usefulness of single pass albumin dialysis: key role of dialysate flow rate

Authors: Mariusz Piechota, Anna Piechota

Published in: Critical Care | Issue 1/2016

Login to get access

Excerpt

In their article in Critical Care, Sponholz et al. [1] compared two devices: the molecular adsorbent recirculating system (MARS) and single pass albumin dialysis (SPAD). As Sponholz et al. claim, SPAD is not an effective method for achieving a significant decrease in the concentration of bile acids, creatinine or urea, because a single SPAD procedure induces a 7.62 % (median) reduction in the level of bile acids and an increase in the concentrations of creatinine and urea by respectively 5.04 % (median) and 4.69 % (median), compared with pre-dialysis levels [1]. In contrast, our as yet unpublished study demonstrates that SPAD can effectively reduce not only the level of bile acids but also the concentration of ammonia. Based on our study, the application of the SPAD method with a dialysate flow rate of 1000 ml/h for a total of around 10 h reduces the level of bile acids by 21.9 % (median) and ammonia by 16.25 % (median). …
Literature
1.
go back to reference Sponholz C, Matthes K, Rupp D, Backaus W, Klammt S, Karailieva D, et al. Molecular adsorbent recirculating system and single-pass albumin dialysis in liver failure—a prospective, randomised crossover study. Crit Care. 2016;20:2.CrossRefPubMedPubMedCentral Sponholz C, Matthes K, Rupp D, Backaus W, Klammt S, Karailieva D, et al. Molecular adsorbent recirculating system and single-pass albumin dialysis in liver failure—a prospective, randomised crossover study. Crit Care. 2016;20:2.CrossRefPubMedPubMedCentral
2.
go back to reference Slowinski T, Morgera S, Joannidis M, Henneberg T, Stocker R, Helset E, et al. Safety and efficacy of regional citrate anticoagulation in continuous venovenous hemodialysis in the presence of liver failure: the Liver Citrate Anticoagulation Threshold (L-CAT) observational study. Crit Care. 2015;19:349.CrossRefPubMedPubMedCentral Slowinski T, Morgera S, Joannidis M, Henneberg T, Stocker R, Helset E, et al. Safety and efficacy of regional citrate anticoagulation in continuous venovenous hemodialysis in the presence of liver failure: the Liver Citrate Anticoagulation Threshold (L-CAT) observational study. Crit Care. 2015;19:349.CrossRefPubMedPubMedCentral
3.
go back to reference Faybik P, Hetz H, Mitterer G, Krenn CG, Schiefer J, Funk GC, et al. Crit Care Med. 2011;39:273–9. Faybik P, Hetz H, Mitterer G, Krenn CG, Schiefer J, Funk GC, et al. Crit Care Med. 2011;39:273–9.
4.
go back to reference Piechota M. Hepatic encephalopathy in the course of alcoholic liver disease—treatment options in the intensive care unit. Anaesthesiol Intensive Ther. 2014;46:34–6.CrossRefPubMed Piechota M. Hepatic encephalopathy in the course of alcoholic liver disease—treatment options in the intensive care unit. Anaesthesiol Intensive Ther. 2014;46:34–6.CrossRefPubMed
5.
go back to reference Sauer IM, Goetz M, Steffen I, Walter G, Kehr DC, Schwartlander R, et al. In vitro comparison of the molecular adsorbent recirculation system (MARS) and single-pass albumin dialysis (SPAD). Hepatol Baltim Md. 2004;39:1408–14.CrossRef Sauer IM, Goetz M, Steffen I, Walter G, Kehr DC, Schwartlander R, et al. In vitro comparison of the molecular adsorbent recirculation system (MARS) and single-pass albumin dialysis (SPAD). Hepatol Baltim Md. 2004;39:1408–14.CrossRef
6.
go back to reference Kortgen A, Rauchfuss F, Götz M, Settmacher U, Bauer M. Albumin dialysis in liver failure: comparison of molecular adsorbent recirculating system and single pass albumin dialysis—a retrospective analysis. Ther Apher Dial. 2009;13:419–25.CrossRefPubMed Kortgen A, Rauchfuss F, Götz M, Settmacher U, Bauer M. Albumin dialysis in liver failure: comparison of molecular adsorbent recirculating system and single pass albumin dialysis—a retrospective analysis. Ther Apher Dial. 2009;13:419–25.CrossRefPubMed
7.
go back to reference Sponholz C, Settmacher U, Bauer M, Kortgen A. Regional citrate anticoagulation for continuous renal replacement therapy in the perioperative care of liver transplant recipients: a single center experience. Ther Apher Dial. 2015;19:8–15.CrossRefPubMed Sponholz C, Settmacher U, Bauer M, Kortgen A. Regional citrate anticoagulation for continuous renal replacement therapy in the perioperative care of liver transplant recipients: a single center experience. Ther Apher Dial. 2015;19:8–15.CrossRefPubMed
8.
go back to reference Sponholz C, Bayer O, Kabisch B, Wurm K, Ebert K, Bauer M, et al. Anticoagulation strategies in venovenous hemodialysis in critically ill patients: a five-year evaluation in a surgical intensive care unit. Sci World J. 2014;2014:1–7.CrossRef Sponholz C, Bayer O, Kabisch B, Wurm K, Ebert K, Bauer M, et al. Anticoagulation strategies in venovenous hemodialysis in critically ill patients: a five-year evaluation in a surgical intensive care unit. Sci World J. 2014;2014:1–7.CrossRef
Metadata
Title
An evaluation of the usefulness of single pass albumin dialysis: key role of dialysate flow rate
Authors
Mariusz Piechota
Anna Piechota
Publication date
01-12-2016
Publisher
BioMed Central
Published in
Critical Care / Issue 1/2016
Electronic ISSN: 1364-8535
DOI
https://doi.org/10.1186/s13054-016-1287-4

Other articles of this Issue 1/2016

Critical Care 1/2016 Go to the issue